4.6 Article

IL-13-mediated immunological control of enterochromaffin cell hyperplasia and serotonin production in the gut

Journal

MUCOSAL IMMUNOLOGY
Volume 6, Issue 1, Pages 146-155

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/mi.2012.58

Keywords

-

Categories

Funding

  1. Canadian Institutes of Health Research (CIHR)
  2. Crohn's and Colitis Foundation of Canada (CCFC)
  3. CIHR New Investigator Award

Ask authors/readers for more resources

Enterochromaffin (EC) cells in the gastrointestinal (GI) mucosa are the main source of serotonin (5-hydroxytryptamine(5-HT)) in the body. 5-HT is implicated in the pathophysiology of many GI disorders including functional and inflammatory bowel disorders. Herein we studied the role of interleukin 13 (IL-13) in EC cell biology by utilizing IL-13-deficient (IL-13 - / -) mice and BON cells (a model for human EC cells). The numbers of EC cells and 5-HT amount were significantly lower in enteric parasite, Trichuris muris - infected IL-13 - / - mice compared with the wild-type mice. This was accompanied with increased parasite burden in IL-13 - / - mice. Treatment of naive and infected IL-13 - / - mice with IL-13 increased EC cell numbers and 5-HT amount. BON cells expressed IL-13 receptor and in response to IL-13 produced more 5-HT. These results provide novel information on IL-13- mediated immunological control of 5-HT in the gut, which may ultimately lead to improved therapeutic opportunities in various GI disorders.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available